Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Multivariate outcome prediction in traumatic brain injury with focus on laboratory values.

Nelson DW, Rudehill A, MacCallum RM, Holst A, Wanecek M, Weitzberg E, Bellander BM.

J Neurotrauma. 2012 Nov 20;29(17):2613-24. doi: 10.1089/neu.2012.2468. Epub 2012 Nov 14.

PMID:
22994879
2.

Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement.

Nelson DW, Thornquist B, MacCallum RM, Nyström H, Holst A, Rudehill A, Wanecek M, Bellander BM, Weitzberg E.

BMC Med. 2011 Mar 2;9:21. doi: 10.1186/1741-7015-9-21.

3.

Extended analysis of early computed tomography scans of traumatic brain injured patients and relations to outcome.

Nelson DW, Nyström H, MacCallum RM, Thornquist B, Lilja A, Bellander BM, Rudehill A, Wanecek M, Weitzberg E.

J Neurotrauma. 2010 Jan;27(1):51-64. doi: 10.1089/neu.2009.0986.

PMID:
19698072
4.

Comparison of a single indicator and gravimetric technique for estimation of extravascular lung water in endotoxemic pigs.

Rossi P, Wanecek M, Rudehill A, Konrad D, Weitzberg E, Oldner A.

Crit Care Med. 2006 May;34(5):1437-43.

PMID:
16557161
5.

Positive inotropic and negative lusitropic effects of endothelin receptor agonism in vivo.

Konrad D, Oldner A, Wanecek M, Rudehill A, Weitzberg E, Biber B, Johansson G, Häggmark S, Haney M.

Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1702-9. Epub 2005 Jun 10.

6.

Cerebral microdialysis of patients with severe traumatic brain injury exhibits highly individualistic patterns as visualized by cluster analysis with self-organizing maps.

Nelson DW, Bellander BM, Maccallum RM, Axelsson J, Alm M, Wallin M, Weitzberg E, Rudehill A.

Crit Care Med. 2004 Dec;32(12):2428-36.

PMID:
15599147
7.

Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.

Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, Weitzberg E.

Crit Care Med. 2004 May;32(5):1192-9.

PMID:
15190972
8.

Comparison of gravimetric and a double-indicator dilution technique for assessment of extra-vascular lung water in endotoxaemia.

Rossi P, Oldner A, Wanecek M, Leksell LG, Rudehill A, Konrad D, Weitzberg E.

Intensive Care Med. 2003 Mar;29(3):460-6. Epub 2003 Feb 8.

PMID:
12577158
9.

Outcome of traumatic brain injuries in 1,508 patients: impact of prehospital care.

Rudehill A, Bellander BM, Weitzberg E, Bredbacka S, Backheden M, Gordon E.

J Neurotrauma. 2002 Jul;19(7):855-68.

PMID:
12184855
10.

Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock.

Wanecek M, Weitzberg E, Alving K, Rudehill A, Oldner A.

Acta Anaesthesiol Scand. 2001 Nov;45(10):1262-70.

PMID:
11736680
11.

Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.

Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M.

Crit Care Med. 2001 Nov;29(11):2185-93.

PMID:
11700420
12.

The endothelin system in septic and endotoxin shock.

Wanecek M, Weitzberg E, Rudehill A, Oldner A.

Eur J Pharmacol. 2000 Oct 27;407(1-2):1-15. Review.

PMID:
11050285
13.

Endothelin(A)-receptor antagonism attenuates pulmonary hypertension in porcine endotoxin shock.

Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E.

Eur Respir J. 1999 Jan;13(1):145-51.

14.

Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.

Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A.

Eur J Pharmacol. 1999 Dec 15;386(2-3):235-45.

PMID:
10618475
15.

Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia.

Oldner A, Wanecek M, Weitzberg E, Sundin P, Sollevi A, Rubio C, Hellström PM, Alving K, Rudehill A.

Br J Pharmacol. 1999 Aug;127(8):1793-804.

16.

Tissue hypoxanthine reflects gut vulnerability in porcine endotoxin shock.

Oldner A, Goiny M, Rudehill A, Ungerstedt U, Sollevi A.

Crit Care Med. 1999 Apr;27(4):790-7.

PMID:
10321671
17.

Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock.

Oldner A, Wanecek M, Weitzberg E, Rundgren M, Alving K, Ullman J, Rudehill A.

Shock. 1999 Feb;11(2):127-35.

PMID:
10030800
18.

The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock.

Oldner A, Wanecek M, Goiny M, Weitzberg E, Rudehill A, Alving K, Sollevi A.

Gut. 1998 May;42(5):696-702.

19.
20.

Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan.

Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E.

Shock. 1997 May;7(5):364-70.

PMID:
9165672
21.

[Therapeutic results in acute skull injuries at KS (Karolinska Hospital) during 25 years. Improved outcome with hyperventilation].

Gordon E, Rudehill A, von Holst H.

Lakartidningen. 1996 Aug 28;93(35):2947-51. Swedish. No abstract available.

PMID:
8815355
22.

Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa.

Lundberg JO, Weitzberg E, Rinder J, Rudehill A, Jansson O, Wiklund NP, Lundberg JM, Alving K.

Eur Respir J. 1996 Jul;9(7):1344-7.

23.

Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.

Weitzberg E, Hemsén A, Rudehill A, Modin A, Wanecek M, Lundberg JM.

Br J Pharmacol. 1996 Jun;118(3):617-26.

24.

Outcome of head injury in 2298 patients treated in a single clinic during a 21-year period.

Gordon E, von Holst H, Rudehill A.

J Neurosurg Anesthesiol. 1995 Oct;7(4):235-47.

PMID:
8563443
25.

Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.

Weitzberg E, Rudehill A, Modin A, Lundberg JM.

Crit Care Med. 1995 May;23(5):909-18.

PMID:
7736750
26.

Inhibitory effects of diclofenac on the endotoxin shock response in relation to endothelin turnover in the pig.

Weitzberg E, Lundberg JM, Rudehill A.

Acta Anaesthesiol Scand. 1995 Jan;39(1):50-9.

PMID:
7725884
27.

Porcine intrinsic pulmonary and systemic vascular tone is endothelin-dependent.

Weitzberg E, Rudehill A, Modin A, Lundberg JM.

Acta Physiol Scand. 1994 Dec;152(4):433-4. No abstract available.

PMID:
7701945
28.

[Handling of organ donors].

Wester K, Lund T, Rudehill A.

Nord Med. 1994;109(6-7):184-5, 196. Norwegian.

PMID:
8015910
29.

Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock.

Weitzberg E, Rudehill A, Lundberg JM.

Eur J Pharmacol. 1993 Mar 16;233(1):85-94.

PMID:
8472750
30.

Pharmacokinetics and effects of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surgery.

Rudehill A, Gordon E, Ohman G, Lindqvist C, Andersson P.

J Neurosurg Anesthesiol. 1993 Jan;5(1):4-12.

PMID:
8431668
31.

Elevated plasma levels of neuropeptide Y upon electrical stimulation of the sympathetic chain in humans.

Rudehill A, Lindqvist C, Lundberg JM.

J Neurosurg Anesthesiol. 1992 Jan;4(1):21-5.

PMID:
15815433
32.

Nitric oxide inhalation selectively attenuates pulmonary hypertension and arterial hypoxia in porcine endotoxin shock.

Weitzberg E, Rudehill A, Alving K, Lundberg JM.

Acta Physiol Scand. 1991 Dec;143(4):451-2. No abstract available.

PMID:
1815479
33.

Elevated plasma levels of endothelin in patients with sepsis syndrome.

Weitzberg E, Lundberg JM, Rudehill A.

Circ Shock. 1991 Apr;33(4):222-7.

PMID:
2065442
34.

Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders.

von Holst H, Rudehill A, Lundberg JM.

Acta Neurochir (Wien). 1991;112(3-4):132-5.

PMID:
1776515
35.

Evidence for release of endothelin-1 in pigs and humans.

Lundberg JM, Ahlborg G, Hemsén A, Nisell H, Lunell NO, Pernow J, Rudehill A, Weitzberg E.

J Cardiovasc Pharmacol. 1991;17 Suppl 7:S350-3.

PMID:
1725378
36.

Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue.

Hemsén A, Franco-Cereceda A, Matran R, Rudehill A, Lundberg JM.

Eur J Pharmacol. 1990 Dec 4;191(3):319-28.

PMID:
1964907
37.

Intensive care in the neurosurgical unit--a review of 2,492 patients.

Gordon E, Rudehill A, von Holst H.

J Neurosurg Anesthesiol. 1990 Sep;2(3):166-74.

PMID:
15815337
39.

Cigarette smoke-induced elevation of plasma neuropeptide Y levels in man.

Rudehill A, Franco-Cereceda A, Hemsén A, Stensdotter M, Pernow J, Lundberg JM.

Clin Physiol. 1989 Jun;9(3):243-8.

PMID:
2743742
40.

Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.

Lundberg JM, Rudehill A, Sollevi A.

Eur J Pharmacol. 1989 Apr 12;163(1):103-13.

PMID:
2744085
41.

Effects of adenosine-induced hypotension on cerebral blood flow and metabolism in the pig.

Stånge K, Lagerkranser M, Rudehill A, Sollevi A.

Acta Anaesthesiol Scand. 1989 Apr;33(3):199-203.

PMID:
2728823
42.

Evidence for co-transmitter role of neuropeptide Y in the pig spleen.

Lundberg JM, Rudehill A, Sollevi A, Hamberger B.

Br J Pharmacol. 1989 Mar;96(3):675-87.

44.

Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.

Mejia JA, Pernow J, von Holst H, Rudehill A, Lundberg JM.

J Neurosurg. 1988 Dec;69(6):913-8.

PMID:
2461438
45.

Influence of adenosine-induced hypotension on the canine myocardium rendered acutely ischaemic by artificial stenosis.

Owall A, Rudehill A, Sylvén C, Sollevi A.

Acta Anaesthesiol Scand. 1988 May;32(4):328-32.

PMID:
3394484
46.

The effect of isoflurane on cerebrospinal fluid pressure in patients undergoing neurosurgery.

Gordon E, Lagerkranser M, Rudehill A, von Holst H.

Acta Anaesthesiol Scand. 1988 Feb;32(2):108-12.

PMID:
3348070
47.

Neuropeptide Y- and alpha-adrenergic receptors in pig spleen: localization, binding characteristics, cyclic AMP effects and functional responses in control and denervated animals.

Lundberg JM, Hemsén A, Rudehill A, Härfstrand A, Larsson O, Sollevi A, Saria A, Hökfelt T, Fuxe K, Fredholm BB.

Neuroscience. 1988 Feb;24(2):659-72.

PMID:
2834666
48.

Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction.

Lundberg JM, Hemsén A, Larsson O, Rudehill A, Saria A, Fredholm BB.

Eur J Pharmacol. 1988 Jan 5;145(1):21-9.

PMID:
2832184
49.

Use of mannitol during neurosurgery: interpatient variability in the plasma and CSF levels.

Anderson P, Boréus L, Gordon E, Lagerkranser M, Rudehill A, Lindquist C, Ohman G.

Eur J Clin Pharmacol. 1988;35(6):643-9.

PMID:
3148472
50.

Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.

Rudehill A, Olcén M, Sollevi A, Hamberger B, Lundberg JM.

Acta Physiol Scand. 1987 Dec;131(4):517-23.

PMID:
3442241

Supplemental Content

Loading ...
Support Center